Literature DB >> 15270878

Increased advanced oxidation protein products in Behçet's disease: a new activity marker?

C Yazici1, K Köse, M Caliş, M DemIr, M Kirnap, F Ateş.   

Abstract

BACKGROUND: Behçet's disease (BD) is a chronic inflammatory disease with unknown pathogenesis. As various functions of neutrophils in peripheral blood, such as chemotaxis, phagocytosis and generation of reactive oxygen species (ROS) increase in BD, ROS-mediated oxidative stress related to neutrophil activation may have an important role in the pathogenesis of BD.
OBJECTIVES: To investigate the importance of neutrophil activation as the main source of oxidative stress through protein oxidation in the pathogenesis of BD, and also to investigate whether one of the products of protein oxidation, advanced oxidation protein products (AOPP), may be used as an activity marker for BD.
METHODS: Patients with BD (n = 49), at active and inactive stages, with or without evidence of uveitis, and healthy volunteers (n = 40) were entered into the study. A full blood count, peripheral blood smears, routine biochemical analyses, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) measurements were performed in all patients preceding the study. Plasma myeloperoxidase (MPO) activity, representing neutrophil activation, and biomarkers of oxidative stress reflecting protein oxidation, such as levels of AOPP and thiol, were measured spectrophotometrically. Statistical comparisons were made using Mann-Whitney U-tests, Student's t-tests, anova/post-anova tests and correlation analyses.
RESULTS: In all patients, the results of full blood count, peripheral blood smears and routine biochemical analyses were in the normal range, but mean values of CRP and ESR were higher than laboratory reference values. Plasma MPO activity and AOPP levels were found to be higher and thiol values lower in the total patient group and individual subgroups than in controls. Patients with active BD had significantly higher MPO and AOPP levels and lower thiol levels than patients with inactive BD. There was no difference between uveitis-positive and uveitis-negative subgroups in MPO and thiol levels, but AOPP levels were lower in the latter group. Patients with active BD +/- uveitis were shown to have increased MPO and AOPP but decreased thiol levels in comparison with the inactive BD, uveitis-negative subgroup. There were strong positive correlations between ESR and CRP, ESR and MPO, ESR and thiol, ESR and AOPP, CRP and MPO, CRP and AOPP, MPO and AOPP, and thiol and AOPP levels in patients with BD.
CONCLUSIONS: Based on this first study, in which MPO-mediated AOPP formation has been demonstrated, it may be suggested that activated neutrophils may play an important role in the pathogenesis of BD and that chlorinated oxidants of neutrophil origin may lead to oxidative stress, notably protein oxidation. Therefore, AOPP may be a useful marker for monitoring the progress and the severity of the disease activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15270878     DOI: 10.1111/j.1365-2133.2004.06003.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  22 in total

1.  Decreased protein S activity is related to the disease activity of Behcet's disease.

Authors:  Seong Ryul Kwon; Mie Jin Lim; Shin Goo Park; Yeon Sook Moon; Won Park
Journal:  Rheumatol Int       Date:  2006-09-13       Impact factor: 2.631

2.  Colchicine modulates oxidative stress in serum and neutrophil of patients with Behçet disease through regulation of Ca²⁺ release and antioxidant system.

Authors:  Selma Korkmaz; Ijlal Erturan; Mustafa Nazıroğlu; Abdulhadi Cihangir Uğuz; Bilal Ciğ; Ishak Suat Övey
Journal:  J Membr Biol       Date:  2011-11-04       Impact factor: 1.843

3.  Neutrophil activation, protein oxidation and ceruloplasmin levels in children with Henoch-Schönlein purpura.

Authors:  Aydin Ece; Selvi Kelekçi; Aşkin Hekimoğlu; Halil Kocamaz; Hasan Balik; Ilyas Yolbaş; Ozcan Erel
Journal:  Pediatr Nephrol       Date:  2007-04-03       Impact factor: 3.714

4.  Levels of F2 isoprostane in Behcet's disease: Correlation with cardiometabolic risk factors.

Authors:  Gul Sagun; Aytekin Oguz; Banu Mesci; Banu Isbilen; Mukaddes Kavala; Havva Keskin; Mumtaz Takir; Sibel Zehra Aydin
Journal:  Redox Rep       Date:  2015-04-13       Impact factor: 4.412

Review 5.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

6.  The association between total antioxidant status and oxidative stress in Behçet's disease.

Authors:  Aylin Sepici-Dinçel; Yeşim Ozkan; Sevgi Yardim-Akaydin; Gülçin Kaymak-Karataş; Meltem Onder; Bolkan Simşek
Journal:  Rheumatol Int       Date:  2006-05-20       Impact factor: 2.631

7.  Ghrelin and obestatin levels in rheumatoid arthritis.

Authors:  Suleyman Serdar Koca; Metin Ozgen; Suleyman Aydin; Sait Dag; Bahri Evren; Ahmet Isik
Journal:  Inflammation       Date:  2008-10       Impact factor: 4.092

8.  Increased plasma myeloperoxidase levels in systemic lupus erythematosus.

Authors:  Rosa Weiss Telles; Gilda Aparecida Ferreira; Neusa Pereira da Silva; Emilia Inoue Sato
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

9.  Serum levels of natriuretic peptides in patients with Behcet's disease.

Authors:  Ramazan Yağci; Yüksel Totan; Ekin Ozlük; Hüseyin Ozyurt; Gülfer Akbay; Meral Ekşioğlu
Journal:  Clin Rheumatol       Date:  2008-04-15       Impact factor: 2.980

10.  Thiol/disulfide homeostasis in patients with ocular-active and ocular-inactive Behçet disease.

Authors:  Mehmet Balbaba; Fatih Ulaş; Hakan Yıldırım; Adem Soydan; Ali Dal; Süleyman Aydın
Journal:  Int Ophthalmol       Date:  2020-06-01       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.